What is RFXCEL?
Founded in 2003 and headquartered in Reno, Nevada, RFXCEL is a pivotal player in ensuring the safety and integrity of the pharmaceutical supply chain. The company provides advanced track-and-trace software solutions tailored for manufacturers, re-packagers, wholesalers, distributors, and dispensers. RFXCEL's technology is instrumental in meeting stringent regulatory requirements and enhancing visibility across complex pharmaceutical distribution networks, thereby safeguarding product authenticity and patient safety.
How much funding has RFXCEL raised?
RFXCEL has raised a total of $30M across 1 funding round:
Series B
$30M
Series B (2017): $30M with participation from Kayne Partners
Key Investors in RFXCEL
Kayne Partners
Kayne Partners, part of Kayne Anderson Capital Advisors, is a prominent investment firm with a focus on growth equity. Their involvement suggests a strategic alignment with RFXCEL's expansion and market development goals.
What's next for RFXCEL?
The enterprise-level funding RFXCEL has attracted, particularly the strategic investment in 2017, positions the company for continued expansion and technological advancement. This capital infusion is likely to fuel further development of its track-and-trace software, enhance market penetration, and potentially explore new verticals within supply chain security. RFXCEL's focus on pharmaceutical safety aligns with increasing global demand for robust supply chain solutions, suggesting a strong outlook for future growth and innovation.
See full RFXCEL company page
